Chemiluminescence Arising From the Oxidation
of Bilirubin in Aqueous Media
Leonidas P. Palilis
1
, Antony C. Calokerinos
1
and Nikos Grekas
2
1
University of Athens, Laboratory of Analytical Chemistry, Panepistimiopolis, Zogfrafou, 157 71 Athens, Greece
2
FARMALEX S. A., Research and Development Laboratory, Tsocha 15–17, 115 10 Athens, Greece
Biomed. Chromatogr. 11, 71–72, (1997) No. of Figures: 2. No. of Tables: 1. No. of Refs: 2.
INTRODUCTION
Bilirubin (BIL) is a compound of great biological interest
since it is found in human plasma as metabolic product of
haemoglobin and haeme proteins. Analytical methods
currently used for the determination of bilirubin are, usually,
spectrophotometric (direct or after diazo reaction), enzy-
matic and high-performance liquid chromatography
(HPLC) methods (Westwood, 1991).
The knowledge of the chemical properties of BIL is
limited mainly due to the lack of stability and solubility of
the compound in water. Nevertheless, it was decided to
investigate the possibility of developing a chemilumines-
cence or bioluminescence analytical procedure for
bilirubin.
Our initial target was to find chemiluminogenic reactions
of BIL in aqueous solutions. It was found that bilirubin
generates chemiluminescence during the action of various
oxidizing agents, such as N-bromosuccinimide, hypo-
chlorite and ferricyanide, in alkaline solutions (Palilis et al.,
1996). The severe interference from albumin diminishes the
value of this procedure, which can only be applied after a
separation step.
Another idea for reducing interference was to use the
enzymatic reaction of bilirubin with bilirubin oxidase and
investigate whether this reaction is bioluminogenic.
Although a weak radiation was generated after mixing the
two reactants, the signal was not analytically useful.
Our attempts were, therefore, focused on the enhance-
ment of this weak radiation, using several molecules as
fluorophores. It was found that luminol generated radiation
during the action of bilirubin oxidase. The intensity of the
radiation is relatively constant for several minutes and is
reduced when BIL is injected into the solution. The height
of the ‘negative’ peak allows the measurement of BIL with
excellent sensitivity and acceptable selectivity. The proce-
dure was found to suffer from less interferences and was
further investigated.
This communication describes the use of the enzymatic
reaction of BIL with bilirubin oxidase in order to investigate
whether this reaction is bioluminogenic with less inter-
ference from other species.
RESULTS AND DISCUSSION
Bilirubin oxidase is an enzyme specific for the oxidation of
BIL through the following process:
Bilirubin + O
2
________
→
Bilirubin oxidase
Biliverdin + H
2
O
Biliverdin + O
2
________
→ Purple compund(s)
Since radiation is emitted immediately after mixing
bilirubin oxidase with luminol and since hydrogen peroxide
is not included in the reacting mixture, the reaction pathway
is different from the well known chemiluminescence
reaction of luminol with hydrogen peroxide. Enzymes such
as cholesterol oxidase, glucose oxidase and horseradish
peroxidase, all of which were used, did not show similar
behaviour, under the same experimental conditions, for the
measurement of BIL.
Hence the reduction of the emission intensity was used as
the analytical signal.
Measurement procedure
A buffer solution of luminol was transferred to the reaction
cell of a batch chemiluminometer, followed by a portion of
bilirubin oxidase. After the signal reached the maximum
level, an aliquot of BIL was injected (Fig. 1).
Effect of pH value
Luminol is soluble in alkaline solution and its chemilumino-
genic properties appear at pH 9–13, with the best response
at a pH around 11. On the other hand, bilirubin oxidase
catalyses the oxidation of both conjugated and unconjugated
bilirubin at less basic pH values (optimum pH 8.2), while in
an acidic medium it catalyses only conjugated bilirubin.
Hence the effect of pH on the decrease of the emission
intensity was examined as a compromise between reactivity
of luminol and action of the enzyme (Fig. 2). The optimum
Correspondence to: L. P. Palilis Figure 1. Schematic diagram of recorded negative peaks.
CCC 0269–3879/97/020071–02 $17.50 Received 30 April 1996
© 1997 by John Wiley & Sons, Ltd. Accepted 21 May 1996
BIOMEDICAL CHROMATOGRAPHY, VOL. 11, 71–72 (1997)